Multisystem Inflammatory Syndrome in Children” (MIS-C) after COVID-19 infection in the Metropolitan Area Nuremberg-Erlangen with a case of MIS-C like disease following SARS-CoV-2 mRNA vaccination

Background Multisystemic inflammatory syndrome in children (MIS-C) is a rare autoimmune reaction that occurs after a latency period following SARS-CoV-2 infection. Its clinical symptoms are similar to the Kawasaki disease including hyperinflammation, gastrointestinal, cardiac, respiratory, and neurological symptoms. Here, we aimed to investigate the incidence, therapeutical procedure and outcome of MIS-C patients in the metropolitan area of Nuremberg-Erlangen, comprising 3,6 million habitants. Further, we report patient with MIS-C with predominating gastrointestinal symptoms associated with SARS-CoV2 mRNA vaccination.